Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,3-Difluoro-6-iodobenzoic acid is a chemical compound with the molecular formula C7H3F2IO2. It is a derivative of benzoic acid, featuring a fluorine atom at the 2 and 3 positions, and an iodine atom at the 6 position. 2,3-Difluoro-6-iodobenzoic acid is recognized for its broad spectrum of industrial and pharmaceutical applications, serving as a fundamental building block in the synthesis of organic compounds and pharmaceuticals.

333780-75-9

Post Buying Request

333780-75-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

333780-75-9 Usage

Uses

Used in Pharmaceutical Industry:
2,3-Difluoro-6-iodobenzoic acid is used as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs. Its unique structure allows for the creation of molecules with specific pharmacological properties, making it a valuable asset in drug design and discovery.
Used in Chemical Industry:
In the chemical industry, 2,3-difluoro-6-iodobenzoic acid is utilized as an intermediate in the production of a range of other chemicals. Its versatility in chemical reactions enables the synthesis of diverse compounds, which can be further processed or used in various applications.
Used in Agrochemical Industry:
2,3-Difluoro-6-iodobenzoic acid has potential applications in the agrochemical field, where it may be employed in the development of new pesticides or other agricultural chemicals. Its chemical properties could be harnessed to create compounds that are effective in controlling pests or improving crop yields.
Used in Material Science:
2,3-Difluoro-6-iodobenzoic acid is used as a building block in the development of new materials, particularly in the realm of organic chemistry. Its incorporation into the molecular structure of these materials can impart unique properties, such as enhanced stability or specific reactivity, which can be beneficial in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 333780-75-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,3,7,8 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 333780-75:
(8*3)+(7*3)+(6*3)+(5*7)+(4*8)+(3*0)+(2*7)+(1*5)=149
149 % 10 = 9
So 333780-75-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H3F2IO2/c8-3-1-2-4(10)5(6(3)9)7(11)12/h1-2H,(H,11,12)

333780-75-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-DIFLUORO-6-IODOBENZOIC ACID

1.2 Other means of identification

Product number -
Other names 2,3-BUTADIONE,[2,3-14C]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:333780-75-9 SDS

333780-75-9Relevant articles and documents

Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite

Hickey, Michael J.,Allen, Paul H.,Caffrey, Moya,Hansen, Peter,Kingston, Lee P.,Wilkinson, David J.

, p. 432 - 438 (2016)

The CXCR2 antagonist AZD5069 has been synthesized in tritium and carbon-14-labelled forms. [3H]AZD5069 was prepared via reductive dehalogenation of an iodinated precursor with tritium gas to provide material with a specific activity of 25.1 Ci/

Measurements of weak halogen bond donor abilities with tridentate anion receptors

Dimitrijevic, Elena,Kvak, Olga,Taylor, Mark S.

supporting information; experimental part, p. 9025 - 9027 (2011/02/16)

The chelate effect of a tridentate receptor is exploited to determine halogen bonding association constants that vary by several orders of magnitude, including interactions of weak donors for which thermodynamic data were not previously available. Free en

Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5- methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor

Dai, Yujia,Hartandi, Kresna,Ji, Zhiqin,Ahmed, Asma A.,Albert, Daniel H.,Bauch, Joy L.,Bouska, Jennifer J.,Bousquet, Peter F.,Cunha, George A.,Glaser, Keith B.,Harris, Christopher M.,Hickman, Dean,Guo, Jun,Li, Junling,Marcotte, Patrick A.,Marsh, Kennan C.,Moskey, Maria D.,Martin, Ruth L.,Olson, Amanda M.,Osterling, Donald J.,Pease, Lori J.,Soni, Niru B.,Stewart, Kent D.,Stoll, Vincent S.,Tapang, Paul,Reuter, David R.,Davidsen, Steven K.,Michaelides, Michael R.

, p. 1584 - 1597 (2008/02/01)

In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors as potential anticancer agents, we discovered, through a structure-based design, that 3-aminoindazole could serve as an efficient hinge-binding template for kinase inhibitors. By incorporating an N,N′-diaryl urea moiety at the C4-position of 3-aminodazole, a series of RTK inhibitors were generated, which potently inhibited the tyrosine kinase activity of the vascular endothelial growth factor receptor and the platelet-derived growth factor receptor families. A number of compounds with potent oral activity were identified by utilizing an estradiol-induced mouse uterine edema model and an HT1080 human fibrosarcoma xenograft tumor model. In particular, compound 17p (ABT-869) was found to possess favorable pharmacokinetic profiles across different species and display significant tumor growth inhibition in multiple preclinical animal models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 333780-75-9